Financial Performance - The company's revenue for Q3 2025 reached ¥6,003,789,053.33, representing a year-on-year increase of 6.75%[4] - The net profit attributable to shareholders was a loss of ¥168,933,000.95, a decline of 393.61% compared to the same period last year[4] - Total operating revenue for the current period is ¥18,211,617,623.42, a decrease of 0.77% from ¥18,352,630,247.47 in the previous period[18] - Net profit for the current period is -¥137,391,974.48, compared to a net profit of ¥205,715,187.28 in the previous period, indicating a significant decline[19] - The total comprehensive income for the period was -149,609,479.15, compared to 211,278,144.29 in the previous period[20] - Basic and diluted earnings per share were both -0.05, down from 0.07 in the previous period[20] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥945,422,070.43, down 22.49% from the previous year[4] - The net cash flow from operating activities was 945,422,070.43, down from 1,219,760,479.13 in the previous period, indicating a decrease of approximately 22.5%[23] - The cash inflow from operating activities totaled 20,056,812,909.88, a slight decrease from 20,213,133,087.95 in the previous period[23] - The cash outflow for purchasing goods and services was 18,010,502,059.47, compared to 17,669,894,371.87 in the previous period, reflecting an increase of about 1.93%[23] - The net cash flow from investing activities was -751,044,464.92, worsening from -595,144,638.27 in the previous period[23] - The cash inflow from financing activities was 5,502,393,618.12, slightly up from 5,501,361,223.44 in the previous period[23] - The net cash flow from financing activities was -89,094,863.97, an improvement from -209,164,311.47 in the previous period[23] - The ending cash and cash equivalents balance was 1,796,045,455.93, compared to 1,575,262,600.77 in the previous period, showing an increase of approximately 14%[23] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥24,744,950,273.64, a decrease of 2.43% from the end of the previous year[4] - Current liabilities totaled ¥9,978,430,260.03, down from ¥10,326,185,709.50, a decrease of about 3.36%[17] - Non-current liabilities decreased to ¥3,100,511,091.60 from ¥3,157,703,298.67, a decline of approximately 1.80%[17] - The company's total equity decreased to ¥11,666,008,922.01 from ¥11,877,274,753.70, reflecting a reduction of about 1.77%[17] Shareholder Information - Total number of common shareholders at the end of the reporting period is 56,604[12] - The largest shareholder, Shandong Energy Group New Materials Co., Ltd., holds 53.18% of shares, totaling 1,511,964,163 shares[12] - The second largest shareholder, Changan International Trust Co., Ltd., holds 2.65% of shares, totaling 75,386,218 shares[12] - The company has a total of 206,749,278 pledged shares by the largest shareholder[12] - The company has a total of 22,794,413 shares held in a repurchase account, representing 0.80% of the total share capital[13] Investment and Financial Assets - The company reported a significant increase of 605.78% in trading financial assets, totaling ¥26,101,835.90[8] - The investment income for the year-to-date period improved by 31.77%, amounting to a loss of ¥16,891,800.00[8] - The company reported an investment loss of -¥16,891,800.00, an improvement from -¥24,757,521.19 in the previous period[19] Inventory and Expenses - The company's inventory increased by 32.08% to ¥1,564,942,977.52 compared to the end of 2024[8] - Total operating costs increased to ¥18,417,312,313.10, up 1.22% from ¥18,195,994,774.86 in the previous period[18] - Research and development expenses for the current period were ¥489,838,854.21, slightly down from ¥510,332,285.17 in the previous period[19] Government Subsidies and Tax - The company recorded a government subsidy of ¥1,230,795.22 for the current period[6] - The company reported a decrease in tax refunds received, totaling 21,025,513.23 compared to 145,805,524.24 in the previous period[22]

Financial Performance - Revenue for Q3 2025 reached ¥591,804,525.96, an increase of 41.26% year-over-year, and total revenue for the year-to-date is ¥1,726,836,067.21, up 67.03% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2025 was ¥113,148,380.58, a significant increase of 317.56% year-over-year, with year-to-date net profit at ¥268,201,511.54, up 216.26%[4] - Basic earnings per share for Q3 2025 was ¥0.09, reflecting a growth of 280.00% year-over-year, while diluted earnings per share also stood at ¥0.09[4] - The company reported a significant reduction in intangible assets by 91.05% to 45,045.16 million, primarily due to the sale of the Espanyol Club[7] - The net profit for the current period is CNY 268,501,323.43, a significant recovery from a net loss of CNY 231,513,811.78 in the previous period[32] - The company reported a total comprehensive income of CNY 284,244,546.45, recovering from a loss of CNY 240,099,609.40 in the prior period[33] Cash Flow and Assets - Cash flow from operating activities for the year-to-date was ¥408,266,801.22, a substantial increase of 259.78% compared to the previous year[4] - Cash and cash equivalents increased by 251.48% to 68,994,572.62 compared to the previous year[43] - The company's current assets totaled RMB 1.12 billion, a substantial increase from RMB 475.20 million at the beginning of the period, representing a growth of approximately 135%[29] - The company's cash and cash equivalents increased to RMB 194.23 million from RMB 92.44 million, marking a growth of approximately 109%[28] - The cash and cash equivalents at the end of the period amounted to CNY 125,029,288.88, compared to CNY 121,281,631.19 at the end of the previous period[36] Liabilities and Equity - The company's total assets decreased by 8.71% from the end of the previous year, amounting to ¥3,460,323,143.65[5] - Shareholders' equity attributable to the parent company increased by 18.93% year-over-year, reaching ¥1,717,990,579.98[5] - The company's total liabilities decreased to RMB 1.75 billion from RMB 2.35 billion, showing a reduction of about 25.6%[30] - Total liabilities decreased significantly, with contract liabilities down by 64.99% and employee compensation payable down by 83.47% due to the sale of the Espanyol Club[11] Research and Development - Research and development expenses decreased by 50.07% year-over-year to ¥39,589,790.32, indicating a strategic shift in investment[8] - Research and development expenses decreased to CNY 39,589,790.32 from CNY 79,283,377.87, a reduction of about 50%[32] Business Segments and Operations - The toy business maintained stable growth in both revenue and net profit, driven by product structure upgrades and deep channel development[22] - New products launched in the toy segment included high-end remote-controlled cars and bicycles, enhancing the product matrix[22] - The game business saw significant revenue contributions from multiple game launches, achieving profitability for the first three quarters[23] - The game "Ragnarok: Dawn" topped the iOS free charts in Taiwan on its launch day, achieving high rankings in various regions[23] - The self-developed strategy game "Three Kingdoms: Strategy in the Nine Provinces" began full-platform public testing in October 2025, ranking first on several app store charts[24] - The company continues to explore deep cooperation opportunities with international IPs to support long-term growth in the toy business[22] Investment and Gains - Non-recurring gains and losses for Q3 2025 totaled ¥50,592,110.32, with significant contributions from asset disposal gains and government subsidies[6] - Investment income increased by 11,806.25% to 5,300.81 million, resulting from the recognition of investment gains from the sale of the Espanyol Club[30] - The company achieved an investment income of CNY 52,559,136.89, a significant improvement from a loss of CNY 448,983.72 in the previous period[32]

Financial Performance - The company's operating revenue for the third quarter reached ¥84,781,750.41, representing a year-on-year increase of 164.39%[3] - The net profit attributable to shareholders was ¥15,943,078.67, an increase of 176.31% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was ¥15,149,596.72, up 168.35% year-on-year[3] - The net profit attributable to the parent company increased by 93.33% year-on-year, driven by the sales profit from the new product[8] - The company's operating profit for the current period was -7,394,530.37, an improvement from -51,330,965.44 in the previous period, indicating a significant reduction in losses[25] - The total profit for the current period was -7,538,875.32, compared to -51,363,813.55 in the previous period, reflecting a substantial decrease in overall losses[25] - The net profit attributable to the parent company's shareholders was -2,523,479.07, a notable improvement from -37,837,689.22 in the previous period[25] Cash Flow - The net cash flow from operating activities increased by 262.79% year-to-date, totaling ¥32,081,773.07[3] - Cash inflow from operating activities totaled 191,244,462.63, compared to 151,475,766.86 in the previous period, showing a year-over-year increase[27] - Cash outflow from operating activities was 159,162,689.56, down from 171,182,964.84 in the previous period, indicating improved cash management[27] - The net cash flow from investing activities was -51,390,022.73, worsening from -16,061,574.38 in the previous period[27] - The net cash flow from financing activities was 2,614,710.40, a significant decrease from 69,322,933.39 in the previous period[27] - The ending cash and cash equivalents balance was 28,699,487.14, down from 37,070,882.11 in the previous period, reflecting a decline in liquidity[27] Assets and Liabilities - The total assets at the end of the reporting period were ¥797,770,471.93, a 1.77% increase from the end of the previous year[3] - The company's total assets increased to ¥797,770,471.93 from ¥783,866,026.52, reflecting a growth of 1.15%[22] - Total liabilities rose to ¥393,424,894.74 from ¥372,260,377.26, marking an increase of 5.1%[22] - The total equity attributable to shareholders decreased to ¥390,893,020.73 from ¥393,409,970.88, a decline of 0.4%[22] - Cash and cash equivalents decreased to ¥28,699,487.14 from ¥45,105,842.30, a drop of 36.2%[20] - Inventory increased to ¥85,659,863.26 from ¥80,535,394.02, an increase of 6.6%[20] - The company’s investment properties decreased to ¥15,493,180.48 from ¥17,597,890.39, a decline of 11.97%[20] Operating Costs and Expenses - The company reported a 33.04% increase in total operating income year-on-year, primarily due to the sales of the newly listed product, paclitaxel injection (albumin-bound)[7] - The cost of goods sold increased by 43.79% year-on-year, attributed to the higher production costs of the new product[7] - Research and development expenses decreased by 39.76% year-on-year, reflecting reduced investment in research activities[8] - Research and development expenses decreased to ¥6,040,736.81 from ¥10,028,401.53, a reduction of 39.6%[24] - Total operating costs decreased slightly to ¥180,108,046.32 from ¥180,496,024.50, with operating costs specifically rising to ¥73,115,398.25 from ¥50,847,128.40, indicating a significant increase of 43.8%[24] - The company experienced a 391.31% increase in non-operating expenses year-on-year, mainly due to increased losses from fixed asset disposals[8] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 44,166[12] - The largest shareholder, Hainan Shuangcheng Investment Co., Ltd., holds 32.92% of the shares, totaling 136,516,546 shares[12] Investment Activities - Investment cash inflows decreased by 55.19% compared to the same period last year, primarily due to a reduction in the recovery of financial investments[10] - Cash paid for investments decreased by 46.30% year-on-year, mainly due to a reduction in financial investments during the reporting period[10] - Net cash flow from investment activities decreased by 219.96% compared to the same period last year, primarily due to a decrease in net cash flow from financial investments[10] - Cash received from investment increased by 262.67% year-on-year, mainly due to an increase in stock subscription payments during the reporting period[10] Audit Status - The company has not undergone an audit for the third quarter financial report[29]

Financial Performance - The company's revenue for Q3 2025 was ¥643,647,540.63, a decrease of 1.96% compared to the same period last year[5]. - The net profit attributable to shareholders was ¥10,682,468.20, down 29.90% year-over-year[5]. - The net profit after deducting non-recurring gains and losses was ¥6,789,290.78, a decline of 47.83% compared to the previous year[5]. - The operating cash flow for the year-to-date period was ¥23,256,149.48, reflecting a significant decrease of 70.82%[5]. - Total operating revenue for the current period is ¥1,882,462,548.88, a decrease of 2.45% compared to ¥1,929,843,801.69 in the previous period[58]. - Net profit for the current period is ¥61,253,540.39, a decline of 5.56% from ¥64,653,431.11 in the previous period[59]. - Operating profit decreased to ¥84,829,692.12, down 13.83% from ¥98,472,510.51 in the previous period[59]. - Basic and diluted earnings per share decreased to ¥0.0657 from ¥0.0686 in the previous period[59]. - The company’s total profit for the current period is ¥83,895,528.42, down from ¥101,956,515.35 in the previous period[59]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,816,126,330.76, an increase of 2.80% from the end of the previous year[5]. - Total current assets increased to ¥1,741,012,968.26 from ¥1,608,572,076.75, reflecting a growth of approximately 8.2%[54]. - Current liabilities decreased slightly to ¥1,370,362,290.32 from ¥1,379,633,066.20, a reduction of approximately 0.2%[55]. - The company reported a total equity of ¥1,866,496,118.04, an increase from ¥1,806,997,755.53, representing a growth of about 3.3%[57]. - The company’s cash and cash equivalents rose to ¥187,951,511.04 from ¥151,393,279.42, marking an increase of approximately 24.2%[54]. - The company’s inventory decreased to ¥202,070,061.15 from ¥214,338,468.42, a decline of about 5.7%[54]. - The company’s retained earnings improved to -¥746,876,506.23 from -¥796,367,861.42, reflecting a positive change of approximately 6.2%[57]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 68,039[11]. - The largest shareholder, Gome Holdings Group Co., Ltd., holds 24.71% of shares, totaling 186,113,207 shares[11]. - Gome Electrical Appliances Co., Ltd. holds 6.64% of shares, totaling 50,000,000 shares[11]. - The number of shares pledged by Gome Holdings Group is 111,601,400, with 182,466,343 shares frozen[12]. - Gome Holdings has pledged 111,601,400 shares, accounting for 59.96% of its holdings, which represents 14.82% of the company's total share capital[16]. - Gome Electrical Appliances has 50,000,000 shares pledged, which is 100% of its holdings, representing 6.64% of the company's total share capital[16]. - The total number of shares under judicial freeze for both Gome Holdings and Gome Electrical Appliances is 172,903,529 shares, representing 73.23% of their total holdings and 22.96% of the company's total share capital[17]. - Gome Holdings has 59,562,814 shares under cumulative pending freeze, which is 32.00% of its holdings and 7.91% of the company's total share capital[18]. - The total number of shares under pending freeze for Gome Electrical Appliances is 2,709,313,426 shares, which is 5,418.63% of its holdings and 359.74% of the company's total share capital[18]. Corporate Governance - The company completed the election of the ninth board of directors and the supervisory board on January 23, 2025[13]. - The new president appointed is Hou Zhajun, along with several vice presidents[14]. - The independent director Dong Lei will no longer serve after the board transition[14]. - The company has established various specialized committees within the new board, including an audit committee and a strategic committee[14]. - The company has no changes in the top 10 shareholders due to securities lending activities[13]. Product Development and Regulatory Approvals - Beijing Huasu received the acceptance notice for the consistency evaluation application of Tramadol Hydrochloride Tablets (50mg), marking the entry into the review stage[30]. - Dodo Pharmaceutical's Eleutherococcus Injection was selected in the national traditional Chinese medicine procurement alliance, with a winning price of 13.18 RMB per 20ml vial[31]. - The procurement cycle for the selected Eleutherococcus Injection lasts until December 31, 2027, which may enhance market coverage and brand influence[32]. - Beijing Huasu's production license was updated to include the production of raw material drug Benzyl Benzoate, enhancing production capacity and compliance with GMP standards[33][34]. - Beijing Huasu's Hydroxycodone Controlled-Release Tablets (40mg) received acceptance for market registration, entering the review phase[37]. - Zhongshi New Materials and Shandong Huasu Health Care Products both received high-tech enterprise certificates, allowing for a reduced corporate income tax rate of 15% for three years[36]. - Duoduo Pharmaceutical's application for the marketing authorization of Bromhexine Hydrochloride Injection (2ml:4mg) has been accepted by the National Medical Products Administration, marking the start of the review phase[38]. - Beijing Huasu's Naloxone Injection (1ml:1mg) has been selected in the 10th batch of national centralized drug procurement, with a winning price of 0.99 RMB per unit, which will enhance the company's market presence and sales channels[39][40]. - Shandong Huasu's application for the marketing authorization of Bisoprolol Amlodipine Tablets (5mg each) has been accepted, indicating progress in the product's market competitiveness[41]. - Duoduo Pharmaceutical's Tramadol Hydrochloride Injection (2ml:100mg) has passed the consistency evaluation for generic drugs, which will positively impact the company's operational performance[46]. - The acceptance of multiple drug applications by the National Medical Products Administration indicates a strategic focus on expanding the product portfolio and enhancing market competitiveness[38][41][44].

Financial Performance - The company's operating revenue for Q3 2025 reached ¥611,378,481.35, representing a year-on-year increase of 14.35% and a cumulative increase of 23.69% for the year-to-date[5] - Net profit attributable to shareholders for Q3 2025 was ¥169,458,642.12, up 14.99% year-on-year, with a year-to-date increase of 29.39% totaling ¥496,134,859.58[5] - The basic earnings per share for Q3 2025 was ¥0.62, reflecting a 14.81% increase compared to the same period last year[5] - Total operating revenue for the current period reached ¥1,781,395,805.57, an increase of 23.7% compared to ¥1,440,203,195.39 in the previous period[22] - The net profit for the current period is CNY 496,134,859.58, an increase of 29.4% compared to CNY 383,454,765.27 in the previous period[23] - The total comprehensive income for the current period is CNY 497,340,817.13, up from CNY 383,803,439.34, reflecting a growth of 29.6%[24] - Basic and diluted earnings per share both increased to CNY 1.82 from CNY 1.41, representing a rise of 29.1%[24] - The company reported a significant increase in sales revenue from CNY 693,546,624.23 to CNY 1,076,242,644.80, reflecting a growth of 55.2%[24] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥6,643,998,971.68, showing a slight increase of 0.35% from the end of the previous year[5] - The company's equity attributable to shareholders increased by 12.05% to ¥3,881,931,442.41 compared to the end of the previous year[5] - Total assets increased slightly to ¥6,643,998,971.68 from ¥6,620,776,016.29, reflecting a growth of 0.35%[21] - Total liabilities decreased to ¥2,762,067,529.27 from ¥3,156,366,470.25, a reduction of 12.5%[21] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥11,329,106.88, a significant increase of 113.40% compared to the same period last year[5] - The net cash flow from operating activities is CNY 11,329,106.88, a significant recovery from a negative CNY 84,554,539.54 in the previous period[24] - Cash inflow from operating activities reached CNY 1,134,249,540.47, compared to CNY 866,664,028.69 in the previous period, marking a growth of 30.8%[24] - The cash flow from investing activities resulted in a net outflow of CNY 43,874,892.80, slightly improved from a net outflow of CNY 47,894,539.53 in the previous period[25] - Cash and cash equivalents at the end of the period totaled CNY 347,031,040.41, compared to CNY 206,551,571.55 at the end of the previous period, indicating an increase of 68.1%[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,738[13] - Major shareholder Li Zhigang holds 39.87% of shares, totaling 109,073,070 shares[13] - The second-largest shareholder, Duan Xiaoting, holds 7.65% of shares, totaling 20,919,394 shares[13] - Li Zhigang directly controls 39.87% of the company's shares and indirectly controls an additional 1.67% through Wuhan Suneng, totaling 41.54%[14] - The company has a total of 105,959,631 restricted shares held by executives, which remain locked under regulations[17] - There are no changes in the number of shares lent or returned under margin trading by the top 10 shareholders[14] - The company has no preferred shareholders or changes in restricted shares during the reporting period[15] - The total number of shares held by the top 10 unrestricted shareholders is also notable, with significant holdings by various funds and individuals[14] - The company maintains a strong governance structure with major shareholders actively involved in management[14] Operating Costs and Expenses - Total operating costs amounted to ¥1,214,834,772.46, up 17.9% from ¥1,029,557,484.51 in the prior period[22] - Research and development expenses were ¥178,453,052.84, a decrease of 15.3% from ¥210,655,964.52 year-over-year[22] - The company incurred a total of CNY 572,097.55 in non-operating expenses, a substantial increase from CNY 33,922.23 in the previous period[23] - The company received CNY 29,459,703.49 in tax refunds, down from CNY 80,836,113.58 in the previous period, indicating a decrease of 63.6%[24] Investment and Financial Assets - The company reported a 211.23% increase in trading financial assets, totaling ¥280,930,419.51, due to investments in cash management products during the reporting period[11] - The company experienced a 58.97% decrease in fair value changes in profit, amounting to ¥10,666,668.51, attributed to reduced fair value changes in equity assets held[11] - Interest income decreased by 30.78% to ¥40,976,742.23, primarily due to a reduction in large-denomination certificates of deposit[11] - The company reported a net cash outflow from financing activities of ¥91,491,707.10, a decrease of 41.35% compared to the previous period, mainly due to share buybacks in the prior year[11] - Long-term investments increased significantly to ¥23,562,971.09 from ¥6,031,351.85, marking a growth of 290.5%[20]

福建三木集团股份有限公司 2025 年第三季度报告 福建三木集团股份有限公司 2025 年第三季度报告 证券代码：000632 证券简称：三木集团 公告编号：2025-96 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 期增减 | | 年同期增减 | | 营业收入（元） | 847,395,268.88 | -67.77% | 4,608,979,663.29 | -51.14% | | 归 ...

Revenue and Profit - Q3 2025 revenue was CNY 1,719,568,456.47, a decrease of 7.00% year-over-year, while year-to-date revenue decreased by 10.20% to CNY 4,937,772,752.89[5] - Net profit attributable to shareholders for Q3 2025 was CNY 407,721,562.17, down 4.37% year-over-year, with a year-to-date net profit of CNY 1,062,397,662.45, a decline of 6.57%[5] - Basic and diluted earnings per share for Q3 2025 were both CNY 0.38, reflecting a decrease of 5.00% compared to the same period last year[5] - Total operating revenue decreased to ¥4,937,772,752.89 from ¥5,498,404,185.59, representing a decline of approximately 10.2% year-over-year[20] - Net profit for the period was ¥1,062,397,662.45, down from ¥1,137,161,185.76, reflecting a decline of approximately 6.6% year-over-year[21] - The company reported a total comprehensive income of ¥1,053,996,074.13, down from ¥1,141,919,894.60, a decrease of approximately 7.7% year-over-year[22] Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 41.25% to CNY 1,520,175,783.00[5] - Cash flow from operating activities generated ¥1,520,175,783.00, an increase from ¥1,076,260,253.42, indicating a growth of approximately 41.2% year-over-year[22] - The net cash flow from investment activities for the year-to-date period was CNY -2,674,229,476.46, an increase of 49.89% in outflows compared to the previous year[11] - Cash inflow from investment activities surged to ¥6,944,768,571.69, up from ¥3,558,697,048.60, marking an increase of about 95.5% year-over-year[22] - Net cash flow from investment activities was negative at approximately -$2.67 billion, compared to -$1.78 billion previously[23] - The net increase in cash and cash equivalents was approximately -$1.36 billion, compared to -$756.31 million previously[23] - The ending balance of cash and cash equivalents was approximately $1.68 billion, down from $2.75 billion[23] Assets and Liabilities - Total assets at the end of the reporting period were CNY 14,956,822,297.46, an increase of 5.08% from the previous year-end[5] - Total non-current assets increased from CNY 6,099,763,341.70 to CNY 7,241,329,322.91, reflecting an increase of about 18.7%[17] - The total assets of the company rose from CNY 14,233,330,315.32 to CNY 14,956,822,297.46, marking an increase of approximately 5.1%[17] - Total current liabilities decreased from CNY 3,959,204,095.80 to CNY 3,604,510,335.97, a reduction of about 8.9%[17] - Total liabilities decreased to ¥4,235,504,818.86 from ¥4,571,348,808.76, a reduction of approximately 7.3%[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 11, with the largest shareholder, Guangdong Meiying Industrial Investment Co., holding 64.36% of shares[13] - The largest shareholder, Guangdong Meiying Industrial Investment Co., also controls several investment partnerships, indicating a consolidated ownership structure[13] - The company has a total of 10 major shareholders, with the top three holding a combined 91.21% of shares[13] Financial Performance Metrics - Financial expenses decreased by 72.49% to CNY -5,997,439.89, mainly due to reduced interest income[10] - Other income decreased by 59.71% to CNY 19,908,355.75, primarily due to a reduction in government subsidies[10] - Total operating costs reduced to ¥3,717,528,878.96 from ¥4,211,084,742.44, a decrease of about 11.7% year-over-year[20] - Deferred income increased to ¥34,259,718.66 from ¥39,672,950.51, indicating a decrease of about 13.8% year-over-year[18] Future Plans and Standards - The company plans to issue 119,492,000 shares in its initial public offering, which is set to be listed on October 22, 2025[14] - The company will implement new accounting standards starting in 2025[25] Audit Status - The third quarter financial report was not audited[24]

Financial Performance - The company's operating revenue for Q3 2025 was ¥755,049,461.54, a decrease of 15.61% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥11,833,931.42, representing a decline of 116.41% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥13,661,385.12, a decrease of 124.69% year-on-year[5]. - Net profit for the current period is -¥98,177,605.47, compared to a net profit of ¥111,848,795.94 in the previous period, indicating a significant decline[21]. - The total comprehensive income for the current period is -¥95,027,820.41, compared to ¥111,294,383.67 in the previous period[22]. - Basic earnings per share for the current period is -¥0.14, compared to ¥0.26 in the previous period[22]. Cash Flow - The net cash flow from operating activities was -¥74,924,519.73, a significant decrease of 195.01% compared to the previous year[11]. - Cash flow from operating activities shows a net outflow of -¥74,924,519.73, contrasting with a net inflow of ¥78,862,667.55 in the previous period[23]. - Net cash flow from investment activities was -21,706,388.41, a decrease from -52,958,683.03 year-over-year[24]. - Net cash flow from financing activities was -393,989,495.24, worsening from -194,723,632.50 year-over-year[24]. - Cash and cash equivalents decreased to ¥932,985,835.77 from ¥1,410,948,355.20, representing a decline of approximately 34%[17]. - Cash inflow from investment activities was 29,160,877.05, an increase from 20,851,076.41 year-over-year[24]. - Total cash inflow from financing activities was 1,292,705,996.32, compared to 1,169,133,545.58 in the previous period[24]. - Total cash outflow from financing activities was 1,686,695,491.56, compared to 1,363,857,178.08 in the previous period[24]. Assets and Liabilities - Total assets at the end of the reporting period were ¥8,781,434,676.74, down 6.69% from the end of the previous year[5]. - Total current assets decreased to ¥3,551,632,538.86 from ¥4,095,017,420.56, a decrease of around 13.4%[17]. - Total liabilities amount to ¥5,698,437,023.39, a decrease from ¥6,014,428,811.64 in the previous period[19]. - The total liabilities of the company decreased to ¥5,287,631,420.32 from ¥5,745,931,000.00, indicating a decline of approximately 8%[18]. - Total equity attributable to shareholders of the parent company is ¥2,847,653,721.45, down from ¥3,115,742,169.81 in the previous period[19]. - Total assets decreased to ¥8,781,434,676.74 from ¥9,410,568,735.27, indicating a decline of about 6.7%[18]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 23,013[12]. - The largest shareholder, Zhejiang Ruiyang Technology Co., Ltd., held 12.55% of the shares, with 46,350,733 shares frozen[13]. Operating Costs and Expenses - Total operating costs for the current period are ¥2,284,362,000.71, down 3.9% from ¥2,377,956,712.16 in the previous period[20]. - Research and development expenses for the current period are ¥301,753,065.62, slightly down from ¥311,207,645.74 in the previous period[20]. - Other income for the current period is ¥125,001,586.15, a decrease from ¥128,787,655.17 in the previous period[20]. Borrowings - Short-term borrowings decreased to ¥456,754,817.44 from ¥789,779,757.06, a reduction of approximately 42.2%[18]. - Long-term borrowings increased to ¥2,461,273,556.47 from ¥2,087,531,658.76, an increase of approximately 18%[18]. - Cash received from borrowings was 895,700,000.00, down from 991,749,861.25 in the previous period[24]. Other Information - The company reported a 66.41% decline in investment income, totaling ¥27,379,019.11 for the first nine months of 2025[10]. - The impact of exchange rate changes on cash and cash equivalents was 202,051.97, slightly up from 187,798.80[24]. - The company’s third-quarter financial report was not audited[25].

Revenue and Profit - Q3 2025 revenue was CNY 195,352,494.92, a decrease of 25.49% year-over-year, and year-to-date revenue was CNY 600,408,014.19, down 35.68% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2025 was CNY 19,912,434.70, an increase of 167.41% year-over-year, while year-to-date net profit reached CNY 366,539,623.12, up 356.65%[4] - Basic and diluted earnings per share for Q3 2025 were both CNY 0.02, reflecting a 140.00% increase compared to the same period last year[4] - The company's total revenue for the first nine months of 2025 was RMB 600.41 million, a decrease of 35.68% compared to RMB 933.50 million in the same period of 2024[12] - Operating profit for the current period was ¥387,541,060.03, compared to a loss of ¥103,154,715.20 in the previous period[26] - Net profit for the current period reached ¥371,074,036.35, a significant recovery from a net loss of ¥141,129,890.36 in the previous period[26] Assets and Liabilities - Total assets as of September 30, 2025, were CNY 5,160,289,670.81, representing a 12.59% increase from the end of the previous year[4] - The total assets increased to ¥5,160,289,670.81 from ¥4,583,263,172.42, representing a growth of 12.6%[22] - Total liabilities decreased to ¥4,459,350,572.47 from ¥5,232,336,817.35, a reduction of 14.8%[23] - Shareholders' equity attributable to the parent company increased to CNY 655,728,473.70, a significant rise of 193.03% compared to the end of the previous year[4] - The equity attributable to shareholders of the parent company improved to ¥655,728,473.70 from a negative equity of -¥704,843,133.55[23] Cash Flow - The company reported a net cash flow from operating activities of CNY 22,235,565.35 year-to-date, down 71.73% compared to the same period last year[4] - The net cash flow from operating activities was RMB 22.24 million, down 71.73% from RMB 78.65 million in the previous year, mainly due to decreased sales receipts[14] - Cash flow from operating activities generated a net cash inflow of ¥22,235,565.35, down from ¥78,649,439.95 in the previous year[28] - The net cash flow from investing activities increased by 129.05% to RMB 11.78 million, attributed to the auction of subsidiary equity under the restructuring plan[14] - Cash inflow from investment activities was ¥50,278,481.45, resulting in a net cash inflow of ¥11,781,483.80, compared to a net outflow of ¥40,562,586.26 last year[29] - The net cash flow from financing activities surged by 1575.45% to RMB 205.61 million, due to the introduction of restructuring investors and receipt of investment funds[14] - Cash flow from financing activities generated a net cash inflow of ¥205,613,656.16, a recovery from a net outflow of ¥13,935,654.39 in the previous period[29] Operational Changes - The company completed a debt restructuring, resulting in a 100% reduction in short-term loans, with a total of CNY 174,805,532.12 eliminated[11] - The company’s contract liabilities increased by 796.99% to CNY 2,866,445.05, indicating a rise in customer prepayments[11] - The company reported a significant decrease in accounts receivable by 76.93% to CNY 20,905,529.08, primarily due to the sale of a subsidiary[11] - Long-term receivables were eliminated entirely, reflecting the impact of the subsidiary's sale as part of the restructuring plan[11] - Operating costs decreased by 43.22% to RMB 410.57 million, primarily due to a reduction in third-party payment business revenue[12] - The company reported cash receipts from sales of goods and services totaling ¥725,378,969.79, down from ¥994,823,851.38 in the prior period[28] - The company incurred cash payments for goods and services amounting to ¥485,993,844.95, a decrease from ¥709,789,302.06 in the previous year[28] Financial Performance - The company reported an investment income of RMB 354.46 million, resulting from the completion of bankruptcy restructuring and recognition of debt restructuring gains[12] - The company’s financial expenses decreased significantly by 108.64% to a negative RMB 10.23 million, due to the completion of debt restructuring[12] - The company's cash and cash equivalents increased to ¥3,896,756,721.11 from ¥3,077,867,584.04, an increase of 26.7%[21] - The company reported a significant reduction in financial expenses, with a net financial cost of -¥10,228,864.79 compared to ¥118,371,694.46 in the previous period[25] - Total comprehensive income amounted to ¥267,624,572.73, a significant increase from a loss of ¥165,162,950.52 in the previous period[27] - Basic and diluted earnings per share were both ¥0.37, compared to a loss of ¥0.26 in the prior period[27] Strategic Developments - The company established a new subsidiary in Hong Kong, named Rindong New Domain Technology Co., Ltd., as part of its strategic expansion[19]

Financial Performance - The company's revenue for Q3 2025 reached ¥70,566,532.27, representing an increase of 87.15% compared to the same period last year[4] - The net profit attributable to shareholders was -¥57,468,774.86, a decrease of 16.60% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥59,194,817.87, down 18.92% from the previous year[4] - Total operating revenue for the period reached ¥140,742,699.34, a significant increase from ¥74,295,930.94 in the previous period, representing an increase of approximately 89.0%[18] - The company reported a net loss of ¥131,392,123.40 for the current period, compared to a net loss of ¥120,735,313.58 in the previous period, indicating an increase in losses of approximately 8.3%[20] - Operating profit was recorded at ¥-126,198,015.27, slightly improved from ¥-137,503,861.56 in the previous period, showing a reduction in operating losses of about 8.5%[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,620,737,030.05, a decrease of 6.56% from the end of the previous year[4] - The owner's equity attributable to shareholders decreased by 15.07% to ¥734,170,509.59 compared to the end of the previous year[4] - Total assets decreased to ¥1,620,737,030.05 from ¥1,734,567,142.19, a decline of about 6.6%[16] - Total liabilities increased to ¥878,297,686.66 from ¥867,424,599.75, reflecting a rise of approximately 1.0%[16] - The company's equity attributable to shareholders decreased to ¥734,170,509.59 from ¥864,449,848.53, a decline of about 15.0%[16] Cash Flow - The company reported a significant increase in cash flow from operating activities, with a net cash flow of -¥72,830,548.20, reflecting a decrease of 28,542.96% year-on-year[4] - Cash flow from operating activities showed a net outflow of ¥72,830,548.20, worsening from a net outflow of ¥254,270.35 in the previous period[22] - Investment activities resulted in a net cash outflow of ¥121,451,930.86, compared to a net outflow of ¥183,920,820.44 in the previous period, indicating an improvement of about 34%[22] - The company received cash inflows from investment activities amounting to ¥584,552,969.38, a substantial increase from ¥77,229,123.45 in the previous period[22] Shareholder Information - The basic earnings per share for the period was -¥0.39, a decline of 14.71% year-on-year[4] - Basic and diluted earnings per share were both reported at ¥-0.88, compared to ¥-0.81 in the previous period, reflecting a decline in earnings per share[20] - The number of convertible bonds converted during the reporting period was 20, with a total conversion of 58 shares[13] - The company holds 3,098,200 shares in its repurchase account, accounting for approximately 2.81% of the total unrestricted circulating shares at the end of the reporting period[11] Operational Metrics - Total operating costs amounted to ¥323,640,175.83, up from ¥271,170,301.69 in the previous period, indicating an increase of about 19.4%[18] - The increase in revenue was primarily driven by the sales growth of new energy storage products[7] - The company's cash and cash equivalents decreased to ¥151,367,221.02 from ¥377,124,684.13, reflecting a decline of approximately 59.9%[14] - Accounts receivable decreased to ¥284,303,227.80 from ¥377,429,789.09, a reduction of about 24.7%[14] - Inventory increased significantly to ¥218,350,813.45 from ¥122,075,302.41, marking an increase of approximately 79.0%[15] Expenses - Research and development expenses decreased to ¥52,333,833.22 from ¥77,367,915.93, a reduction of approximately 32.4%[20] - Financial expenses increased significantly to ¥33,309,952.40 from ¥12,980,908.70, marking an increase of about 157.5%[20] - The company's weighted average return on net assets was -7.53%, a decrease of 2.64% compared to the same period last year[4]